The store will not work correctly when cookies are disabled.
3-Bromo-4-oxo-1-(3'-deoxy-beta-D-ribofuranosyl)pyrazolo[3,4-d]-pyrimidine
ID: ALA4874629
PubChem CID: 164628839
Max Phase: Preclinical
Molecular Formula: C10H11BrN4O4
Molecular Weight: 331.13
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]cnc2c1c(Br)nn2[C@@H]1O[C@H](CO)C[C@H]1O
Standard InChI: InChI=1S/C10H11BrN4O4/c11-7-6-8(12-3-13-9(6)18)15(14-7)10-5(17)1-4(2-16)19-10/h3-5,10,16-17H,1-2H2,(H,12,13,18)/t4-,5+,10+/m0/s1
Standard InChI Key: BIDWPRMVBBJVAS-LBACSGLVSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
2.2974 -28.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1225 -28.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3781 -27.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7078 -27.4312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0460 -27.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2609 -27.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1635 -27.6630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0856 -26.8550 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6043 -29.3691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2468 -26.8824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4216 -26.8814 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5036 -27.6678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8356 -28.1506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9189 -28.9669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6696 -29.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3378 -28.8179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2511 -28.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9151 -27.5161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7292 -26.2179 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
5 6 1 1
3 7 1 1
6 8 1 0
2 9 1 6
7 13 1 0
12 10 1 0
10 11 2 0
11 7 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 12 1 0
17 18 2 0
10 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.13 | Molecular Weight (Monoisotopic): 329.9964 | AlogP: -0.48 | #Rotatable Bonds: 2 |
Polar Surface Area: 113.26 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.31 | CX Basic pKa: ┄ | CX LogP: -0.88 | CX LogD: -0.88 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.69 | Np Likeness Score: 0.50 |
References
1. Bouton J, Ferreira de Almeida Fiuza L, Cardoso Santos C, Mazzarella MA, Soeiro MNC, Maes L, Karalic I, Caljon G, Van Calenbergh S.. (2021) Revisiting Pyrazolo[3,4-d]pyrimidine Nucleosides as Anti-Trypanosoma cruzi and Antileishmanial Agents., 64 (7.0): [PMID:33784107] [10.1021/acs.jmedchem.1c00135] |